Atlas Trials

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

Clinical trial NCT03353597 · UNKNOWN

Trial details

NCT number
NCT03353597
Sponsor
Chandra Duggirala
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Aging
Start date
2018-05-15
Primary completion
2020-06-15
Enrollment
2120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.